Live Breaking News & Updates on Vascular Biogenics Daily
Stay updated with breaking news from Vascular biogenics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ VBLT opened at $0.16 on Monday. Vascular Biogenics has a fifty-two week low of $0.10 and a fifty-two week […] ....
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 8.8 % Shares of VBLT opened at $0.16 on Monday. The company has a market cap of $12.11 million, a PE ratio […] ....
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. The business has a 50 day simple moving average of $0.20 and […] ....
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. Vascular Biogenics has a 1 year low of $0.10 and a 1 year […] ....
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance VBLT stock opened at $0.25 on Wednesday. The business has a 50-day moving average price of $0.24 and a 200 day […] ....